BioSpace News Archive

Pharm Country

MedRisk’s 2018 Industry Trends Report Points to Conservative Care

While workers’ compensation claims frequency and occupational injury rates have declined over the past few years, the number of claims involving physical and/or occupational therapy rose by 13 percent, according to MedRisk’s 2018 Industry Trends Report on Physical Medicine and Workers’ Comp.

December 11, 2018
·
2 min read
Business

In2Bones Expands Its Lead in PEEK Lower Extremity Implants with the Global Launch of the Unique PitStop® Subtalar Implant

n2Bones Global, Inc. today announced the global launch of the unique, “see-through” PitStop® implant.

December 11, 2018
·
2 min read
Business

Ron Klain Joins BrainScope Board of Directors

Brings Extensive Experience in Industry, Government and Public Health

December 11, 2018
·
4 min read
Business

Dr. Klemens Schulz Appointed CPO of the L&R Corporate Group

L&R is represented in all important markets around the world and will realize a revenue of more than 650 million euros in 2018.

December 11, 2018
·
1 min read
Pharm Country

BD Announces Completion Of Enterprise Level Cybersecurity Assessment From UL

BD FACSLyric™ Flow Cytometer is First BD Product to Earn UL Cybersecurity Assurance Program Certification

December 11, 2018
·
4 min read
Business

Avanir Pharmaceuticals Announces Termination of License Agreement with Optinose for ONZETRA® Xsail®

Optinose is a global specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists.

December 11, 2018
·
2 min read
Business

Adoption Momentum For Paradigm4’s UK Biobank Platform

Paradigm4 is announcing that another top 15 pharma company has selected Paradigm4 to exploit the power of the UK Biobank data.

December 11, 2018
·
2 min read
Biotech Bay

GenEdit Closes $8.5 million Series Seed Financing

GenEdit, Inc. today announced the completion of a $8.5 million Series Seed financing round led by new investors Data Collective Bio (DCVC Bio) and SK Holdings.

December 11, 2018
·
3 min read
Dr. Reddy’s announces the launch of over-the-counter store brand equivalent of Prilosec OTC® (Omeprazole Delayed-Release) Tablets, 20 mg in the U.S. Market

Dr. Reddy’s Laboratories Ltd. announced today the launch of Omeprazole Delayed-Release Tablets, 20 mg, an over-the-counter (OTC) store-brand equivalent of Prilosec® OTC (omeprazole delayed-release) Tablets, 20 mg, in the United States market as approved by the U.S. Food and Drug Administration (USFDA).

December 11, 2018
·
3 min read
Drug Development

Acerus Announces Results of Phase 1 Clinical Trial with a Proprietary Intranasal Formulation of a Tetrahydrocannabinol-Rich Cannabis Oil

The THC trial, previously announced on October 24, 2018, involved 12 overnight-fasting, healthy subjects with prior cannabis experience.

December 11, 2018
·
3 min read